Article: China’s largest e-cigarette brand Relx to study health effects of vaping amid regulatory crackdowns

Meridiano

Add Article

Article Details

Impact Score

5 / 10

AI Summary (Processed Content)

China's leading e-cigarette brand, Relx, has established a new bioscience laboratory in Shenzhen to research the health effects of vaping. The lab will study the short- and long-term impacts on systems like cardiovascular and respiratory health, using models and animal testing, aiming to scientifically assess if e-cigarettes are less harmful than traditional cigarettes.

This initiative follows recent Chinese regulatory crackdowns, including bans on online sales of e-cigarettes across various digital platforms. The company states its goal is to provide scientific evidence and offer smokers a potentially reduced-harm alternative.

The main topics covered are Relx's new health research laboratory, the scientific study of e-cigarette effects, and the context of increased regulatory scrutiny on e-cigarettes in China.

Original URL

https://www.scmp.com/tech/science-research/article/3102028/chinas-largest-e-cigarette-brand-relx-study-health-effects?utm_source=rss_feed

Source Feed

Science & Research - South China Morning Post

Published Date

2020-09-18 08:30

Fetched Date

2026-03-04 14:32

Processed Date

2026-03-04 15:12

Embedding Status

Present

Cluster ID

Not Clustered

Raw Extracted Content

China’s largest e-cigarette brand Relx to study health effects of vaping amid regulatory crackdowns
- Relx’s China’s largest e-cigarette brand, has a new bioscience lab in Shenzhen to study the health effects of vaping
- In the past year, China has banned online sales of e-cigarettes on e-commerce sites as well as on short video and live-streaming platforms
Are electronic cigarettes a safe alternative to smoking?
“E-cigarettes are sometimes viewed with suspicion because we have incomplete knowledge,” said Relx co-founder and head of R&D and supply chain Wen Yilong.
The company unveiled a new bioscience laboratory on Thursday to study the health effects of vaping. The lab in Shenzhen will investigate the short- and long-term behavioural impacts of e-cigarettes compared to traditional cigarettes using 3D printed models of human lungs, Relx said. It will also examine the impact of Relx products on animal cardiovascular, respiratory and nervous systems by testing them on mice.
“The Relx bioscience lab’s mission is to explore the unknown,” Wen said at a press conference on Thursday. “We want to collect evidence through a scientific approach and strive to prove the potential for e-cigarettes to be less harmful, and in doing so, provide users with the option to choose an alternative.”
The move comes after recent regulatory crackdowns on online e-cigarette sales in China, which is the world’s largest market for smokers with 300 million smokers – or almost a third of the global total – according to the WHO.